---
title: "Arbutus Pharma (ABUS.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/ABUS.US/norm.md"
symbol: "ABUS.US"
name: "Arbutus Pharma"
parent: "https://longbridge.com/zh-CN/quote/ABUS.US.md"
datetime: "2026-05-20T12:40:21.714Z"
locales:
  - [en](https://longbridge.com/en/quote/ABUS.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ABUS.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ABUS.US/norm.md)
---

# Arbutus Pharma (ABUS.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | 0.8700 | -0.0195 | -0.0404 | 0.0100 | -0.1300 |
| ROE | 403.13% | -19.51% | -38.62% | 12.45% | -111.15% |
| 营业收入 | 179.13M | 1.05M | 529000.00 | 10.74M | 1.76M |
| 净利润 | 169.69M | -3.76M | -7.74M | 2.52M | -24.53M |
| 营业利润 | 169.12M | -7.64M | -8.29M | 1.91M | -13.03M |
| 毛利率 | 97.70% | -376.31% | -992.25% | 48.80% | -407.88% |
| 净利率 | 94.73% | -357.37% | -1463.52% | 23.49% | -1390.36% |
| 利润含金量 | -2085.29% | - | - | -12.15% | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 277.16M | 94.62M | 97.71M | 103.27M | 117.01M |
| 权益乘数 | 1.07 | 1.24 | 1.26 | 1.24 | 1.48 |
| 每股净资产 | 1.32 | 0.3977 | 0.4032 | 0.4330 | 0.4134 |
| 资产周转率 | 0.9714 | 0.1244 | 0.1227 | 0.1171 | 0.0479 |
| 现金及短投 | 95.23M | 91.47M | 93.70M | 98.09M | 112.71M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 22000.00 | 32000.00 | 137000.00 | 148000.00 | 168000.00 |
| 净债务 | -91.32M | -87.28M | -89.10M | -93.09M | -107.11M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -8.11M | -4.68M | -5.82M | -15.75M | -13.39M |
| 投资现金流 | 2.20M | -1.36M | -10.02M | 15.61M | 11.35M |
| 融资现金流 | 11.62M | 1.64M | 844000.00 | 453000.00 | 2.78M |
| 自由现金流 | -72.72M | -1.94M | -2.53M | -13.32M | 77125.00 |
| 现金流充裕率 | - | - | - | - | - |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | - | - | - | - | - |